Integrated Proteins secures BSE listing for new equity shares

Integrated Proteins Ltd. has announced that it has secured listing approval from the BSE for 1,55,10,000 equity shares. These shares, each with a face value of Rs. 10, were issued at a premium of Rs. 1.25. The shares were issued to non-promoters on a preferential basis, following the conversion of warrants.

The company is mandated to ensure compliance with Regulation 167 of SEBI (ICDR) Regulations and other SEBI specifications. Furthermore, if there is a change exceeding two percent of the total paid-up share capital, Integrated Proteins must file its shareholding pattern in XBRL mode as per Regulation 31(1)(c) of SEBI LODR Regulations, 2015.

Trading approval for these newly listed shares will be granted only after the company files listing approval from the National Stock Exchange of India Ltd. (if applicable) and confirmation letters from NSDL/CDSL regarding the crediting of shares to beneficiary accounts and admission of capital to the depository system. Non-compliance with the requirement to apply for trading approval within seven working days of listing approval will incur a fine.